Email this article 
Hide
Show all
Original Research
Red blood cell alloimmunisation in multi-transfused patients from an haemodialysis service in Burkina Faso
Submitted: 12 May 2021 | Published: 26 September 2022
About the author(s)
Koumpingnin Nebie, National Blood Center of Ouagadougou, Ouagadougou, Burkina Faso; and, Laboratory of Haematology, Department of Fundamental Sciences, Health Sciences Research and Training Unit, University Joseph KI-ZERBO, Ouagadougou, Burkina FasoSalam Sawadogo, National Blood Center of Ouagadougou, Ouagadougou, Burkina Faso; and, Laboratory of Haematology, Department of Fundamental Sciences, Health Sciences Research and Training Unit, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
Salifo Sawadogo, National Institute for Medical Sciences, University Nazi Boni, Bobo-Dioulasso, Burkina Faso; and, Souro Sanou Teaching Hospital, Bobo-Dioulasso, Burkina Faso
Jérôme Koulidiati, Laboratory of Haematology, Department of Fundamental Sciences, Health Sciences Research and Training Unit, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso; and, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso
Habi Y.A. Lengani, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso
Abdoul G. Sawadogo, National Blood Center of Ouagadougou, Ouagadougou, Burkina Faso
Jérôme Babinet, Centre National de Référence pour les Groupes Sanguins (CNRGS), National Institute for Blood Transfusion, Paris, France
Mohammed Khalloufi, French Establishment of Blood, Bobigny, France
Saliou Diop, Department of Haematology, University Cheikh Anta Diop, Dakar, Senegal
Eléonore Kafando, Laboratory of Haematology, Department of Fundamental Sciences, Health Sciences Research and Training Unit, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso; and, Laboratory of Haematology, Paediatric Teaching Hospital Charles de Gaulle, Ouagadougou, Burkina Faso
Abstract
Background: In Burkina Faso, red blood cell (RBC) transfusion remains the crucial anaemia treatment following chronic renal failure (CRF) as erythropoietin and its analogues are unavailable. However, blood group matching beyond the ABO and Rhesus is not common in Burkina Faso. Thus, alloimmunisation is a potential issue for transfused patients.
Objective: Our study aimed to identify anti-erythrocyte antibodies in multi-transfused CRF patients at the Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.
Methods: This cross-sectional study, conducted from October 2018 to November 2019, included CRF patients who had received at least two RBC units. We screened patients for the presence of RBC antibodies using three commercial Cells panels and identified antibody specificities for positive screenings using 11 Cells panels for an indirect antiglobulin test (IAT) in a low ionic strength microcolumn gel-card system.
Results: Two hundred and thirty-five patients (45.1% female; average age: 41.5 years) were included. The median number of blood units received per patient was 10 (interquartile range: 5–20). The overall alloimmunisation rate was 5.9% (14/235). Antibodies identified included: anti-D (1 case), anti-C (1 case), anti-D+C (4 cases), anti-CW (1 case), anti-E (1 case), anti-S (1 case) and anti-Lea (1 case). In four positive patients, the specificity of the antibodies was indeterminate. No risk factors were associated with alloimmunisation.
Conclusion: In Burkina Faso, screening for RBC alloantibodies should be mandated for patients at risk. The high rate of indeterminate antibodies suggests the need to develop a local RBC antibody panel adapted to the local population.
Keywords
Metrics
Total abstract views: 2123Total article views: 2252
Crossref Citations
1. Feasibility and performance of in-house red blood cell reagents to detect unexpected antibodies in immunized patients in Burkina Faso
S. Sawadogo, K. Nebie, D. Kima, S.K.A. Ouedraogo, P.A. Nagnon, J. Koulidiati, C. Traore, S. Sawadogo, E. Kafando, V. Deneys
Immunohematology vol: 39 issue: 4 first page: 172 year: 2023
doi: 10.2478/immunohematology-2023-025